Remgro and MSC completed the acquisition of Mediclinic for £3.7bn.

Remgro, an investment holding company, and MSC, a container shipping and a company, completed the acquisition of Mediclinic, a private hospitals group, for £3.7bn ($4.5bn). “I am delighted that Remgro is participating in this transaction, which is fully aligned with our strategy of prioritising our ownership of structurally attractive, unlisted assets. Since its founding, Remgro has been a long-standing and supportive shareholder of Mediclinic. We are proud of what the business has achieved over that period and look forward to continuing our support, alongside our partner SAS, as the business transitions to the next phase of its evolution under stable, long-term ownership. Under the stewardship of the Consortium, Mediclinic will be well-positioned to execute on its strategy and undertake the investment required to realise the full potential of the business,” Jannie Durand, Remgro CEO.